Episode
The New Era of Weight Loss and Heart Health with Robert Eckel
- Podcast
- Weight Loss And ...
- Published
- Jul 15, 2026
- Duration seconds
- 3056
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/weight-loss-and-6741102/episodes/the-new-era-of-weight-loss-and-heart-health-with-robert-eckel/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/weight-loss-and-6741102/the-new-era-of-weight-loss-and-heart-health-with-robert-eckel.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Cancer is the disease most people fear. But heart disease is the one that actually kills the most Americans, and most people never connect it to their weight. For decades, obesity was treated as a bystander to heart disease, a risk factor at best. That thinking has changed dramatically, and the data behind that shift is stunning: we now have a medication proven to cut major cardiovascular events by 20% in people with obesity. Join Holly and Jim as they sit down with an old friend and true legend in the field, Dr. Robert Eckel, Professor Emeritus at the University of Colorado Anschutz Medical Campus. Bob is the only person to have ever served as president of the American Heart Association, the American Diabetes Association, and the Obesity Society, a hat trick that connects heart, metabolism, and weight in a way no one else in medicine can claim. He's been in the room for four decades of major turning points in this field, from the earliest meetings on obesity science to the current GLP-1 era. In this episode, Bob walks Holly and Jim through the science, the skepticism, and the surprises behind the biggest shift in obesity treatment of their careers and answers real listener questions about medications, guidelines, and what patients should actually be asking their doctors. Discussed in the episode: The pivotal trial that's changing how cardiologists think about weight loss drugs and how its results stack up against statins Why the outcome researchers expected to explain the benefits of these medications may not be the real story at all The surprising history of how "obesity" and "heart disease" became connected in medical thinking, and who had to make the case What your body's "set point" really is, and whether staying on medication long-term can actually change it A ca…